Arteris, Inc. (NASDAQ:AIP - Get Free Report) VP Paul Alpern sold 4,750 shares of the firm's stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $11.08, for a total transaction of $52,630.00. Following the sale, the vice president owned 65,960 shares in the company, valued at approximately $730,836.80. This trade represents a 6.72% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
Arteris Trading Up 23.7%
Shares of Arteris stock traded up $2.60 on Monday, hitting $13.58. 4,397,458 shares of the company traded hands, compared to its average volume of 565,523. The firm's 50-day simple moving average is $9.65 and its 200 day simple moving average is $8.43. The company has a market cap of $579.19 million, a P/E ratio of -16.56 and a beta of 1.45. Arteris, Inc. has a 12-month low of $5.46 and a 12-month high of $14.58.
Arteris (NASDAQ:AIP - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) earnings per share for the quarter, meeting the consensus estimate of ($0.11). The firm had revenue of $16.50 million for the quarter, compared to analysts' expectations of $16.35 million. Arteris had a negative net margin of 52.41% and a negative return on equity of 8,546.17%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Analysts predict that Arteris, Inc. will post -0.73 earnings per share for the current year.
Analyst Upgrades and Downgrades
AIP has been the topic of several research reports. Weiss Ratings restated a "sell (d-)" rating on shares of Arteris in a research report on Saturday, September 27th. Wall Street Zen raised shares of Arteris from a "sell" rating to a "hold" rating in a research note on Monday, September 15th. Finally, TD Cowen boosted their price target on shares of Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Three research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $15.00.
Read Our Latest Stock Analysis on Arteris
Institutional Trading of Arteris
Several hedge funds have recently added to or reduced their stakes in the business. Cambridge Investment Research Advisors Inc. purchased a new position in shares of Arteris in the first quarter valued at about $95,000. Acadian Asset Management LLC raised its stake in shares of Arteris by 40.6% during the first quarter. Acadian Asset Management LLC now owns 900,723 shares of the company's stock valued at $6,222,000 after acquiring an additional 260,277 shares during the last quarter. Jacobs Levy Equity Management Inc. raised its stake in shares of Arteris by 48.5% during the first quarter. Jacobs Levy Equity Management Inc. now owns 249,517 shares of the company's stock valued at $1,724,000 after acquiring an additional 81,516 shares during the last quarter. Squarepoint Ops LLC bought a new position in shares of Arteris during the fourth quarter valued at about $160,000. Finally, Nuveen LLC bought a new position in shares of Arteris during the first quarter valued at about $349,000. 64.36% of the stock is owned by institutional investors.
About Arteris
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.